According to MoonLake Immunotherapeutics's latest financial reports and stock price the company's current number of shares outstanding is 73,915,296. At the end of 2026 the company had 73,915,296 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.